For the quarter ending 2026-03-31, ENSC has $2,167,803 in assets. $2,836,815 in debts. $745,482 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 745,482 | 4,310,354 | 1,673,218 | 2,211,575 |
| Unbilled receivable | - | 420,345 | 4,411 | 1,204,979 |
| Prepaid expenses and other current assets | 1,263,058 | 2,511,769 | 1,250,641 | 1,865,041 |
| Total current assets | 2,008,540 | 7,242,468 | 2,928,270 | 5,281,595 |
| Property and equipment, net | 117,596 | 124,129 | 123,643 | - |
| Other assets | 41,667 | 85,882 | 127,551 | 292,860 |
| Total assets | 2,167,803 | 7,452,479 | 3,179,464 | 5,574,455 |
| Other long-term liabilities | - | - | 35 | 1,033 |
| Total long-term liabilities | - | - | 35 | 1,033 |
| Accounts payable | 1,610,186 | 3,267,610 | 463,458 | 1,042,832 |
| Accrued expenses and other liabilities | 980,780 | 993,411 | 1,453,555 | 1,045,657 |
| Notes payable and accrued interest | 245,849 | 306,708 | 387,702 | 424,521 |
| Total current liabilities | 2,836,815 | 4,567,729 | 2,304,715 | 2,513,010 |
| Total liabilities | 2,836,815 | 4,567,729 | 2,304,750 | 2,514,043 |
| Common stock, 0.0001 par value, 250,000,000 shares authorized at march 31, 2026 and december 31, 2025 9,277,825 and 4,574,983 shares issued at march 31, 2026 and december 31, 2025, respectively 9,277,819 and 4,574,977 shares outstanding at march 31, 2026 and december 31, 2025, respectively | 929 | 459 | 320 | 241 |
| Additional paid-in capital | 142,935,443 | 142,933,260 | 138,155,394 | 136,612,043 |
| Accumulated deficit | -143,276,414 | -139,719,999 | -136,952,351 | -133,223,223 |
| Total ensysce biosciences, inc. stockholders equity (deficit) | -340,042 | 3,213,720 | 1,203,363 | 3,389,061 |
| Noncontrolling interests in stockholders equity (deficit) | -328,970 | -328,970 | -328,649 | -328,649 |
| Total stockholders equity (deficit) | -669,012 | 2,884,750 | 874,714 | 3,060,412 |
| Total liabilities and stockholders equity (deficit) | 2,167,803 | 7,452,479 | 3,179,464 | 5,574,455 |
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)